ClinicalTrials.gg
Not yet recruitingNCT07850531PNODUpdated Sep 30, 2026

Precision Nutrition for Obesity and Prediabetes Prevention in Under-supported Communities

An interventional study of Precision Nutrition Intervention and Standard Nutrition Counseling in Obesity & Overweight and Prediabetes, sponsored by Prairie View A&M University. Not yet recruiting at 1 site in United States. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-09-30.

Sponsored by Prairie View A&M University · Not applicable, Interventional, and Treatment

Updated Sep 30, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

This randomized controlled trial will evaluate the effectiveness of a culturally sensitive precision nutrition intervention for improving obesity- and diabetes-related outcomes among African American and Hispanic/Latino adults who are overweight, obese, or have prediabetes. Participants will be randomized to either a precision nutrition intervention group or a control group receiving standard nutrition counseling and educational materials. The intervention incorporates individualized dietary recommendations based on participant characteristics, including dietary habits, physical activity, socioeconomic factors, psychosocial factors, phenotype, and genotype. Outcomes will be assessed at baseline, 6 weeks, and 12 weeks and will include body weight, diet quality, fasting blood glucose, hemoglobin A1C, body composition, physical activity, blood pressure, and metabolic biomarkers. Feasibility, acceptability, and sustainability of the intervention will also be evaluated.

Read the detailed description

Obesity and prediabetes are major public health concerns and disproportionately affect under-supported populations, including African American and Hispanic/Latino communities. Traditional nutrition interventions often use a one-size-fits-all approach and may not adequately account for individual variability in biological, behavioral, and environmental factors that influence health outcomes. Precision nutrition is an emerging approach that tailors nutrition recommendations to individual characteristics such as dietary intake, physical activity, health status, genotype, phenotype, psychosocial influences, and environmental exposures. Advances in nutrition science, artificial intelligence, and machine learning have created opportunities to integrate these factors and deliver more personalized dietary and lifestyle recommendations. The purpose of this study is to determine whether a culturally sensitive precision nutrition intervention can improve obesity and type 2 diabetes risk factors among African American and Hispanic/Latino adults living in Texas. The study will recruit adults aged 18 to 65 years with overweight, obesity, and/or prediabetes. Participants will be randomized to either an intervention group or a control group. The intervention group will receive tailored nutrition counseling, individualized meal planning, physical activity guidance, behavior-change education, and access to a mobile-health platform to support healthy lifestyle modification. The intervention will incorporate motivational interviewing techniques and social support resources. The control group will receive standard nutrition counseling and educational materials. Data collection will occur at baseline, 6 weeks, and 12 weeks. Measures will include sociodemographic information, dietary intake, food security, anthropometric and body composition assessments, physical activity, blood pressure, fasting blood glucose, hemoglobin A1C, lipid profile, genetic markers, gut microbiome measures, inflammatory markers, and cognitive assessments. Qualitative interviews and focus group discussions will be used to explore participant experiences and intervention acceptability. Primary outcomes include changes in body weight, diet quality, and fasting blood glucose. Secondary outcomes include changes in hemoglobin A1C, body composition, blood pressure, lipid profile, physical activity levels, feasibility, acceptability, compliance, and sustainability of intervention effects. Findings from this study will provide preliminary evidence regarding the effectiveness and feasibility of precision nutrition approaches for obesity and diabetes prevention in under-supported populations.

02

Conditions studied

  • Obesity & Overweight
  • Prediabetes

Keywords

  • Precision Nutrition
  • Personalized Nutrition
  • Weight Loss
  • Diabetes Prevention
  • Nutrition Counseling
  • Physical Activity
  • Culturally Sensitive Intervention
  • African American Adults
  • Hispanic/Latino Adults
  • Prediabetes
  • Obesity
03

In context

Obesity

11,543 studies on the registry are indexed under Obesity; 2,047 are open to participants now.

This study's planned enrollment of 100 is above the median of 67 across 9,023 interventional studies indexed under Obesity.

Browse Obesity studies →

Lead sponsor

Prairie View A&M University is the lead sponsor of 2 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults aged 18 to 65 years
  • African American or Hispanic/Latino adults
  • Residents of Texas
  • (BMI) ≥ 25 kg/m² and/or fasting blood glucose levels of 100-125 mg/dL
  • (HbA1C) between 5.7% and 6.4%
  • Daily access to a cell phone and the internet
  • Able to participate in moderate-to-vigorous physical activity
  • Able and willing to provide

Exclusion criteria

Exclusion Criteria:

  • Do not meet the inclusion criteria
  • Following a prescribed diet for any reason, including weight loss, within the previous 3 months
  • Diagnosed diabetes mellitus
  • Cardiovascular disease
  • Eating disorders
  • Lung disease
  • Liver disease
  • Thyroid disease
  • Crohn's disease
  • Pregnant
  • Lactating
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

HbA1c

A blood test of average blood sugar over the past two to three months, given as a percentage or in mmol/mol. 6.5% (48 mmol/mol) or more is the usual threshold for diabetes, normally confirmed by a second test.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
100 participants (estimated)

Study arms

  • Experimental
    Precision Nutrition Intervention

    Participants will receive a culturally sensitive precision nutrition intervention including individualized nutrition counseling, personalized meal planning, physical activity guidance, health behavior lessons, mobile-health support, motivational interviewing, and social support resources.

    Behavioral: Precision Nutrition Intervention

  • Active comparator
    Standard Nutrition Counseling Control

    Participants will receive standard nutrition counseling and dietary education materials without individualized precision nutrition recommendations.

    Behavioral: Standard Nutrition Counseling

Interventions

  • BehavioralPrecision Nutrition Intervention

    A personalized precision nutrition program tailored to participants' dietary habits, physical activity, socioeconomic characteristics, psychosocial factors, phenotype, and genotype. The intervention includes nutrition counseling, physical activity guidance, behavioral education, mobile-health support, and social support activities.

  • BehavioralStandard Nutrition Counseling

    Standard nutrition counseling and educational materials are delivered in accordance with usual nutrition education practices.

    Also known as: Standard Nutrition Counseling Control

06

What researchers measure

Primary outcomes

  1. Change in Body Weight

    Change in measured body weight, expressed in kilograms (kg), from baseline following participation in the precision nutrition intervention or standard nutrition counseling control condition.

    Time frame: Baseline, 6 weeks, and 12 weeks

  2. Change in Healthy Eating Index (HEI)-2020 Total Score

    Change in Healthy Eating Index (HEI)-2020 total score derived from participants' dietary intake data collected using 24-hour dietary recalls. HEI-2020 scores range from 0 to 100, with higher scores indicating better diet quality and greater adherence to the Dietary Guidelines for Americans.

    Time frame: Baseline, 6 weeks, and 12 weeks

  3. Change in Fasting Blood Glucose

    Change in fasting blood glucose concentration, expressed in milligrams per deciliter (mg/dL), from baseline following participation in the precision nutrition intervention or standard nutrition counseling control condition.

    Time frame: Baseline, 6 weeks, and 12 weeks

Secondary outcomes

  1. Change in Hemoglobin A1C (HbA1C)

    Change in haemoglobin A1C concentration, expressed as a percentage of total haemoglobin (%), as a measure of long-term glycemic control.

    Time frame: Baseline, 6 weeks, and 12 weeks

  2. Change in Body Fat Percentage

    Change in body fat percentage (%) measured using body composition assessment methods.

    Time frame: Baseline, 6 weeks, and 12 weeks

  3. Change in Skeletal Muscle Mass

    Change in skeletal muscle mass, expressed in kilograms (kg), measured using body composition assessment methods. Change in skeletal muscle mass, expressed in kilograms (kg), measured using body composition assessment methods.

    Time frame: Baseline, 6 weeks, and 12 weeks

  4. Change in Waist Circumference

    Change in waist circumference, expressed in centimeters (cm), measured using standardized anthropometric procedures.

    Time frame: Baseline, 6 weeks, and 12 weeks

  5. Change in Body Mass Index (BMI)

    Change in body mass index (BMI), calculated as weight in kilograms divided by height in meters squared (kg/m²).

    Time frame: Baseline, 6 weeks, and 12 weeks

  6. Change in Average Daily Step Count

    Change in average daily step count measured using a pedometer.

    Time frame: Baseline, 6 weeks, and 12 weeks

  7. Change in Energy Expenditure

    Change in activity-related energy expenditure, expressed in kilocalories per day (kcal/day), measured using a pedometer or activity-monitoring device.

    Time frame: Baseline, 6 weeks, and 12 weeks

  8. Change in Blood Pressure

    Change in Change in systolic and diastolic blood pressure measurements, expressed in millimeters of mercury (mmHg), measured using standardized procedures.

    Time frame: Baseline, 6 weeks, and 12 weeks

  9. Change in Lipid Profile

    Change in total cholesterol, LDL cholesterol, HDL cholesterol, and triglyceride concentrations, expressed in milligrams per deciliter (mg/dL).

    Time frame: Baseline, 6 weeks, and 12 weeks

  10. Program Compliance

    Percentage of prescribed nutrition counseling activities, dietary recommendations, and physical activity recommendations completed by participants during the intervention period.

    Time frame: Throughout study completion (up to 12 weeks)

  11. Participant Recruitment Rate

    Percentage of eligible individuals who enroll in the study among all individuals screened for participation.

    Time frame: Throughout study completion (up to 12 weeks)

  12. Participant Retention Rate

    Percentage of enrolled participants who complete all study assessments through the end of the intervention period.

    Time frame: Throughout study completion (up to 12 weeks)

  13. Participant Satisfaction Questionnaire Score

    Participant satisfaction with the intervention measured using a study-specific satisfaction questionnaire. The level of satisfaction will be scored on a likert scale.

    Time frame: Throughout study completion (up to 12 weeks)

  14. Program Favorability Questionnaire Score

    Participant perceptions of the intervention measured using a study-specific program favorability questionnaire. Scores will be on a likert scale that reflects perceptions of the intervention.

    Time frame: Throughout study completion (up to 12 weeks)

07

Study locations

1 site
  • integrated Nutrition Intervention for Community and Health Enhancement Laboratory (iNICHE Lab)
    Prairie View, Texas 77446, United States
    • Janet Antwi, B.Pharm, M.S, Ph.D, RPh, RD, · Contactjaantwi@pvamu.edu · 9362612536
    • Janet Antwi, B.Pharm, M.S, Ph.D, RPh, RD, · Principal investigator
08

References and documents

Publications

  • de Toro-Martin J, Arsenault BJ, Despres JP, Vohl MC. Precision Nutrition: A Review of Personalized Nutritional Approaches for the Prevention and Management of Metabolic Syndrome. Nutrients. 2017 Aug 22;9(8):913. doi: 10.3390/nu9080913. PubMed 28829397 ↗
  • Jinnette R, Narita A, Manning B, McNaughton SA, Mathers JC, Livingstone KM. Does Personalized Nutrition Advice Improve Dietary Intake in Healthy Adults? A Systematic Review of Randomized Controlled Trials. Adv Nutr. 2021 Jun 1;12(3):657-669. doi: 10.1093/advances/nmaa144. PubMed 33313795 ↗
  • Livingstone KM, Ramos-Lopez O, Perusse L, Kato H, Ordovas JM, Martinez JA. Precision nutrition: A review of current approaches and future endeavors. Trends in Food Science and Technology. 2022.
  • Ordovas JM, Ferguson LR, Tai ES, Mathers JC. Personalised nutrition and health. BMJ. 2018 Jun 13;361:bmj.k2173. doi: 10.1136/bmj.k2173. PubMed 29898881 ↗
  • Celis-Morales C, Livingstone KM, Marsaux CF, Macready AL, Fallaize R, O'Donovan CB, Woolhead C, Forster H, Walsh MC, Navas-Carretero S, San-Cristobal R, Tsirigoti L, Lambrinou CP, Mavrogianni C, Moschonis G, Kolossa S, Hallmann J, Godlewska M, Surwillo A, Traczyk I, Drevon CA, Bouwman J, van Ommen B, Grimaldi K, Parnell LD, Matthews JN, Manios Y, Daniel H, Martinez JA, Lovegrove JA, Gibney ER, Brennan L, Saris WH, Gibney M, Mathers JC; Food4Me Study. Effect of personalized nutrition on health-related behaviour change: evidence from the Food4Me European randomized controlled trial. Int J Epidemiol. 2017 Apr 1;46(2):578-588. doi: 10.1093/ije/dyw186. PubMed 27524815 ↗

Individual participant data

Plan to share: Yes — De-identified individual participant data underlying the results reported in publications, including demographic, dietary, anthropometric, physical activity, metabolic, and survey data collected during the study.

Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Analytic code

Time frame: Beginning 12 months following publication of the primary study results. Data will be available for up to 5 years following publication of the primary study results.

Access criteria: De-identified data will be made available to qualified researchers whose proposed use of the data has been approved by the study investigators. Requests should include a methodologically sound research proposal. Data sharing may require execution of an institutional data use agreement and compliance with applicable ethical and regulatory requirements.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Oct 2026; primary completion for Aug 2027, 10 months later.

Of 3,690 non-industry interventional studies with no phase under Obesity, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 43. This study's planned 10 months is below that.

Counting every sponsor, half of 3,853 studies reached it within 22 months; a quarter within 9 and three quarters within 42.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 14, 2026
First posted
Sep 30, 2026
StartEst.
Oct 1, 2026
Primary completionEst.
Aug 31, 2027
CompletionEst.
Aug 31, 2027
Last update
Sep 30, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Sep 30, 2026
Show all 1 update
  1. Sep 30, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07850531
Lead sponsor
Prairie View A&M University
Collaborators
United States Department of Agriculture (USDA)
Responsible party
Janet Antwi (Associate Professor, Prairie View A&M University) — Principal investigator
First posted
Sep 30, 2026
Start date
Oct 1, 2026 (estimated)
Primary completion
Aug 31, 2027 (estimated)
Completion
Aug 31, 2027 (estimated)
Last update
Sep 30, 2026

Study contacts

Janet Antwi, B.Pharm, M.S, Ph.D, RPh, RD,
Contact
jaantwi@pvamu.edu
9362612536
Obed Akwaa Harrison, PhD, MSc(R), RNutr.
Contact
oaharrison@pvamu.edu
9362612522
Janet Antwi, B.Pharm, M.S, Ph.D, RPh, RD,
principal investigator · Prairie View A&M University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion